Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus Paricalcitol

RATIONALE & OBJECTIVE: Mineral and bone disorder in chronic kidney disease (CKD) is associated with progression of coronary artery calcification (CAC). Mineral and bone disorder often is treated with calcitriol and other vitamin D receptor activators, including paricalcitol, agents that may have...

Descripción completa

Detalles Bibliográficos
Autores principales: Anis, Karim H., Pober, David, Rosas, Sylvia E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406841/
https://www.ncbi.nlm.nih.gov/pubmed/32775985
http://dx.doi.org/10.1016/j.xkme.2020.05.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406841/
https://www.ncbi.nlm.nih.gov/pubmed/32775985
http://dx.doi.org/10.1016/j.xkme.2020.05.009

Ejemplares similares